GOUT

This study is testing whether a new medication called AR882 can effectively lower uric acid levels and reduce painful gout attacks. It involves 750 people with gout who will take either AR882 or a placebo for 12 months. Researchers want to see if AR882 helps prevent gout flares a…

This study is testing if a medicine for severe, hard-to-treat gout can be given safely and effectively every four weeks instead of every two weeks. It involves about 260 adults whose gout is not controlled by standard pills. The main goal is to see if the less frequent schedule w…

This study is testing if following up with patients by email helps doctors better control gout. The goal is to see if regular email check-ins help adjust medication doses to reach a target level in the blood, which can dissolve the crystals that cause gout pain. It compares this …

This study tests whether providing educational materials and care coordination help in emergency departments can improve how people with gout manage their condition. Researchers are enrolling 200 adults with gout to see if this approach helps them get better follow-up care after …

This study aims to find a better way to treat sudden gout attacks in people with advanced kidney disease or kidney transplants. It compares two medications—anakinra and prednisone—to see which one reduces pain faster and with fewer side effects. The trial involves about 200 hospi…

This project is not a new treatment trial, but a large-scale analysis of past research. Researchers are compiling and reviewing results from many existing diet studies to understand if replacing animal protein (like meat and dairy) with plant protein (like beans and nuts) leads t…